Eli Lilly Total Assets increased by 3.6% to $116.58B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.4%, from $89.39B to $116.58B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 19.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Universal financial metric used by all public companies to define the size of the balance sheet.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $47.81B | $48.19B | $48.81B | $46.92B | $47.06B | $47.46B | $49.49B | $53.16B | $54.81B | $57.92B | $64.01B | $63.94B | $71.87B | $75.61B | $78.72B | $89.39B | $100.92B | $114.94B | $112.48B | $116.58B |
| QoQ Change | — | +0.8% | +1.3% | -3.9% | +0.3% | +0.8% | +4.3% | +7.4% | +3.1% | +5.7% | +10.5% | -0.1% | +12.4% | +5.2% | +4.1% | +13.6% | +12.9% | +13.9% | -2.1% | +3.6% |
| YoY Change | — | — | — | — | -1.6% | -1.5% | +1.4% | +13.3% | +16.5% | +22.0% | +29.3% | +20.3% | +31.1% | +30.5% | +23.0% | +39.8% | +40.4% | +52.0% | +42.9% | +30.4% |
| Segment | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 |
|---|---|---|---|---|---|
| Reportable Segment | $64.01B | $78.71B | $89.39B | $100.92B | $114.94B |
| Total | $64.01B | $78.72B | $89.39B | $100.92B | $114.94B |
Reportable Segment was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.